An observational study in Cerebral Palsy, Muscle Contracture and Spasticity, Muscle, sponsored by Eva Ponten. Recruiting at 3 sites in Sweden. Open to participants aged 2 Years to 18 Years. Per ClinicalTrials.gov, last updated 2022-08-26.
Sponsored by Eva Ponten · Observational
Among 19 studies in Cerebral Palsy with a site in Sweden — 9 open to participants now, 10 under way, none of them phase 3. Cerebral Palsy · Sweden.
Among the 19 studies in Cerebral Palsy with a site in Sweden, this one is one of 2 that started in 2002, is one of 9 observational ones, and was the 11th registered.
1,936 studies on the registry are indexed under Cerebral Palsy; 458 are open to participants now.
This study's planned enrollment of 150 is above the median of 63 across 472 observational studies indexed under Cerebral Palsy.
Browse Cerebral Palsy studies →9 of the 19 studies in Cerebral Palsy with a site in Sweden are open now, in 1 country. Each count lists the studies.
Of the 270 Cerebral Palsy studies recruiting now, 27 (10%) set no upper age limit and 235 (87%) stop at 75 or younger; 255 take children under 18; 51 take healthy volunteers.
This study: 2 Years to 18 Years · all sexes.
The full table on the hub →19 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 2 started in 2002.
Median enrollment 28 across the 10 interventional studies, 150 across the 9 observational. Of the 7 that completed or were terminated, 1 (14%) have results posted.
2 of 19 have an industry lead sponsor. The 10 most frequent:
Eva Ponten is the lead sponsor of 3 studies on the registry; 3 are open to participants now.
Eva Ponten has 3 studies filed under Cerebral Palsy — fewer than ten, so there is no comparison to draw.
6 of the studies in Cerebral Palsy with a site in Sweden that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05867940Region SkaneEffects of Physical Activity on Prescription (PAP) as a Health-enhancing Intervention in People With Disabilities | 2026-12 |
| NCT05497609Eva PontenThe Muscle in Children With Cerebral Palsy - Longitudinal Exploration of Microscopic Muscle Structure. | 2026-12-15 |
| NCT07374432Karolinska InstitutetFull Speed Ahead: For Joyful Movement and Health | 2026-12-30 |
| NCT07025694Lund UniversityExercise Training Among Children With Cerebral Palsy to Increase Health and Well-being - A Feasibility Study | 2026-12-31 |
| NCT05901259Otto Bock Healthcare Products GmbHThe EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes | 2027-08-01 |
Among the 19 studies in Cerebral Palsy with a site in Sweden, from their registry updates:
Nothing recorded among them since 2026-09-25.
Cerebral palsy (CP) is a motor impairment due to a brain malformation or a brain lesion before the age of two. Spasticity, hypertonus in flexor muscles, dyscoordination and an impaired sensorimotor control are cardinal symptoms. The brain lesion is non-progressive, but the flexor muscles of the limbs will during adolescence become relatively shorter and shorter (contracted), forcing the joints into a progressively flexed position. This will worsen the positions of already paretic and malfunctioning arms and legs. Due to bending forces across the joints, bony malformations will occur, worsening the function even further. Currently, the initial treatment of choice is the use of braces, which diminishes the shortening somewhat, but eventually lengthenings of tendons and release of aponeuroses around the muscles often is needed, and transfers of wrist flexors to wrist extensors may improve wrist position. But the long-term results are unpredictable- how much does the muscle need to be lengthened? What muscles should be transferred for a better position of the wrist, and at what tension? A method to measure sarcomere length in vivo has been developed. The sarcomere, the distance between two striations, is the smallest contractile unit in the striated muscle. When, during surgery, a muscle fiber bundle is transilluminated with a low energy laser light, a diffraction pattern is formed. This diffraction pattern reflects the sarcomere length, and thereby an instant measure of how the stretch of the muscle is obtained. When performing tendon transfers of e.g. wrist flexors to wrist extensors, the setting of the tension of the transfer is arbitrary, and the long-term result is unpredictable. Laser diffraction measurements will give a guide to a precise setting of tension. It is known that there may be pathological changes in muscle in cerebral palsy that also will affect the long-term results of tendon lengthenings and transfers. In order to also take these changes into account, small muscle biopsies will be taken during the same surgeries. These will be examined with immuno-histochemical and biochemical techniques, gel-electrophoresis as well as electron microscopy.
Cerebral palsy (CP) is a motor impairment due to a brain malformation or a brain lesion before the age of two. Spasticity, hypertonus in flexor muscles, dyscoordination and an impaired sensorimotor control are cardinal symptoms. The brain lesion is non-progressive, but the flexor muscles of the limbs will during adolescence become relatively shorter and shorter (contracted), forcing the joints into a progressively flexed position. This will worsen the positions of already paretic and malfunctioning arms and legs. Due to bending forces across the joints, bony malformations will occur, worsening the function even further. Currently, the initial treatment of choice is the use of braces, which diminishes the shortening somewhat, but eventually lengthenings of tendons and release of aponeuroses around the muscles often is needed, and transfers of wrist flexors to wrist extensors may improve wrist position. But the long-term results are unpredictable- how much does the muscle need to be lengthened? What muscles should be transferred for a better position of the wrist, and at what tension? A method to measure sarcomere length in vivo has been developed. The sarcomere, the distance between two striations, is the smallest contractile unit in the striated muscle. When, during surgery, a muscle fiber bundle is transilluminated with a low energy laser light, a diffraction pattern is formed. This diffraction pattern reflects the sarcomere length, and thereby an instant measure of how the stretch of the muscle is obtained. When performing tendon transfers of e.g. wrist flexors to wrist extensors, the setting of the tension of the transfer is arbitrary, and the long-term result is unpredictable. Laser diffraction measurements will give a guide to a precise setting of tension. It is known that there may be pathological changes in muscle in cerebral palsy that also will affect the long-term results of tendon lengthenings and transfers. In order to also take these changes into account, small muscle biopsies will be taken during the same surgeries. These will be examined with immuno-histochemical and biochemical techniques, gel-electrophoresis as well as electron microscopy.
Research questions:
Significance: Children with cerebral palsy have a motor impairment and progressive contractures that we often treat late; when tendon and bony surgery are the only options to realign the joints. More information on the muscle architecture, composition and growth potential will give more knowledge the reasons for increasing flexion contractures in children with cerebral palsy. With this knowledge, hopefully new treatment regimens and improved surgical techniques for this patient group can be developed.
Children who due to clinical indications need surgery of the arm or the lower leg. Patients are consecutively recruited.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
No intervention
Sarcomere lenght measurements intraooperatively in vivo with laser diffraction
micrometer
Time frame: One hour
Muscle biopsy structure, fiber area
square mm
Time frame: one hour
Muscle biopsy gene expression and protein content
percentage %
Time frame: one hour
Plan to share: Undecided
No publications or documents are linked to this record.
Started Jan 2002 (actual). Primary completion is estimated for Dec 2032, 371 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.